|
||||||||
|
||||||||
|
Questions on Life Satisfaction - Cystic Fibrosis (FLZM -CF)Name of QuestionnaireQuestions of Life Satisfaction-Cystic Fibrosis (FLZM-CF) DescriptionA disease specific life satisfaction instrument, to assess cystic fibrosis specific life satisfaction in the prior 4 weeks. Developed for use by adolescent (age = 16 years) and adult patients with a diagnosis of cystic fibrosisDeveloperL Goldbeck, TG Schmitz, G Henrich, PHerschbachAddressL. GoldbechUniversity Clinic of Child and Adolescent Psychiatry/Psychotherapy SteinhÖvestr. 5 D89075 Ulm Germany Cost & availabilityInstrument is published as an appendix (1)AdministrationSelf-administeredTime to complete5 minutesNumber of items9 Domains & categories9 domains and 1 summary scoreName of categories/domainsNine dimensions of CF life satisfaction: breathing difficulties/coughing, abdominal pain/digestive trouble, eating, sleep, routine therapy, adherence to daily therapy, significance for others, understanding, and free from disadvantageScaling of items
ScoringScores for each section and a total score. Weighted scores for each dimension domains is calculated using the following formula: weighted satisfaction = (importance rating-1) x [(2 x satisfaction rating)-5] Summary score is calculated by summing the 9 weighted scores. Item specific weighted scores range from -12 to +20. The summary score ranges from -112 to 180. Higher scores indicate higher satisfaction with health status ReliabilityValidityConvergent validity shown with significant correlations with the general health summary score and the general life satisfaction scores of the FLZM. Significant correlations have been documented between total score and measure of disease activity (FEV1) but not body mass index.1ResponsivenessParticipants of inpatient rehabilitation programs show a significant increase in FLZM-C scores.3 Discriminant ability has been noted with differences in patient groups (FEV1> 70% of predicted compared to FEV1; = 70; heart lung transplant recipents compared to non recipients). 1Research useReported.1 The generic instrument (FLZM) has been reported in subjects with CF1,2 and in patient with inflammatory bowel disease.3 The FLZM-CF has been used with CF-patients in an evaluation of an inpatient rehabilition program6 and in a longitudinal study with CF-outpatients.4Clinical useNot reported.LanguageOriginal: GermanTranslations: English (FLZM-CF) References
Date of informationJanuary 2005 |
|||||||
Copyright © 2007 American Thoracic Society · Web Site Requirements |
||||||||